Survival following primary surgery for oral cancer
- PMID: 18674959
- DOI: 10.1016/j.oraloncology.2008.05.008
Survival following primary surgery for oral cancer
Abstract
The main aims of this article are to report the overall and disease-specific survival of a consecutive series of patients presenting with oral cancer from 1992 to 2002 and to relate survival to clinical and pathological factors. The article uses population-based age-sex mortality rates in the North-West of England to highlight differences in overall and disease-specific survival. 541 patients with oral squamous cell carcinoma presented to the Regional Maxillofacial Unit from 1992 to 2002. Curative treatment favoured radical primary surgery, 10% (52) received primary radiotherapy. These patients were on average 8 years older with more advanced tumours and overall poorer survival at 5 years, 23% (SE 7%). The remainder of the results refer to 489 patients who had primary curative surgery, 40% (194) of whom received adjuvant radiotherapy. The overall survival (OS) was 56% (SE 2%) and the disease-specific survival (DSS) was 74% (SE 2%). There was a local recurrence rate of 10% (50) and the loco-regional recurrence rate was 21% (103). The second primary rate was 7% (35). Survival figures had improved over the 10-year period from 63% DSS for the first 4 years of the study (1992-1995) compared to 81% for the last 3 years (2000-2002). In stepwise Cox regression the two predictors selected for disease-specific survival were pN status and margins (both p<0.001). Age-sex mortality rates for the North-West indicate that 15.0% of the 489 primary surgery patients might have been expected to die within 5 years if they were typical of the general population and the observed difference between all causes and oral-cancer specific survival was 18.3%. These data emphasise the value of disease-specific survival as an indicator of successful treatment in a cohort that tends to be elderly, from social deprived backgrounds, with life styles and comorbidity that influence overall survival.
Similar articles
-
Primary tumor site as a predictor of treatment outcome for definitive radiotherapy of advanced-stage oral cavity cancers.Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1011-9. doi: 10.1016/j.ijrobp.2009.09.074. Epub 2010 Apr 29. Int J Radiat Oncol Biol Phys. 2010. PMID: 20434273
-
The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.Laryngoscope. 2005 Apr;115(4):629-39. doi: 10.1097/01.mlg.0000161338.54515.b1. Laryngoscope. 2005. PMID: 15805872
-
Predictors of locoregional recurrence in early stage oral cavity cancer with free surgical margins.Oral Oncol. 2010 Jan;46(1):49-55. doi: 10.1016/j.oraloncology.2009.10.011. Epub 2009 Dec 14. Oral Oncol. 2010. PMID: 20005769
-
Oral cavity squamous cell carcinoma in 260 patients aged 80years or more.Radiother Oncol. 2009 Dec;93(3):516-23. doi: 10.1016/j.radonc.2009.07.015. Epub 2009 Aug 21. Radiother Oncol. 2009. PMID: 19699545
-
Squamous cell carcinoma of the buccal mucosa: an aggressive cancer requiring multimodality treatment.Head Neck. 2006 Feb;28(2):150-7. doi: 10.1002/hed.20303. Head Neck. 2006. PMID: 16200628
Cited by
-
Molecular expression of Forkhead Box C2 gene (FOXC2) and Prospero homeobox gene (PROX-1) in oral squamous carcinoma and their correlation with clinicopathological parameters: A prospective cohort study.J Oral Maxillofac Pathol. 2024 Apr-Jun;28(2):216-225. doi: 10.4103/jomfp.jomfp_394_23. Epub 2024 Jul 11. J Oral Maxillofac Pathol. 2024. PMID: 39157851 Free PMC article.
-
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer.J Immunother Cancer. 2024 Jul 22;12(7):e009278. doi: 10.1136/jitc-2024-009278. J Immunother Cancer. 2024. PMID: 39038919 Free PMC article.
-
Prognostic value of a mandibular canal staging system for primary lesions in patients with lower gingival squamous cell carcinoma: a multicenter, retrospective study.Int J Clin Oncol. 2024 Aug;29(8):1122-1132. doi: 10.1007/s10147-024-02542-y. Epub 2024 May 2. Int J Clin Oncol. 2024. PMID: 38696052
-
Prognostic factors of oral squamous cell carcinoma: the importance of recurrence and pTNM stage.Maxillofac Plast Reconstr Surg. 2024 Mar 4;46(1):8. doi: 10.1186/s40902-024-00410-3. Maxillofac Plast Reconstr Surg. 2024. PMID: 38433140 Free PMC article.
-
Assessment of knowledge and awareness among North Indian populations about oral precancerous lesions (OPL): A cross-sectional survey study.Natl J Maxillofac Surg. 2023 Sep-Dec;14(3):454-459. doi: 10.4103/njms.njms_150_22. Epub 2023 Nov 10. Natl J Maxillofac Surg. 2023. PMID: 38273904 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical